Literature DB >> 33144824

Risk Factors of Postoperative Complications in Laparoscopic Cholecystectomy for Acute Cholecystitis.

Manabu Sato1, Koujin Endo1, Akihiko Harada1, Masahiro Shijo2.   

Abstract

INTRODUCTION: There are often cases with postoperative complications after laparoscopic cholecystectomy (LC), resulting in severe consequences. This study aimed to identify potential risk factors of postoperative complications in cases of LC for acute cholecystitis.
MATERIALS AND METHODS: A total of 423 patients with cholecystitis underwent LC. We divided the patients into two groups: group without postoperative complications (Group A) and group with postoperative complications (Group B). Pre-operative findings, surgical findings, and the methods for evaluating the risk of peri-operative complications were compared between the two groups with a univariate analysis. Independent risk factors of postoperative complications were then evaluated in a multivariate analysis with the factors shown to be statistically significant in the univariate analysis.
RESULTS: A Physiological and Operative severity Score for enUmeration of Mortality and morbidity (POSSUM) of ≥ 48.3 and moderate or severe cholecystitis were independent risk factors of postoperative complications in LC.
CONCLUSIONS: This study indicated that POSSUM morbidity and moderate or severe cholecystitis were potential risk factors of postoperative complications. The pre-operative management of the general condition and cholecystitis using antibiotics, infusion, percutaneous transhepatic gallbladder drainage, and other approaches may be significant for the prevention of postoperative complications. Once the POSSUM morbidity reaches the threshold after LC, postoperative management becomes difficult, so strict control of the general condition should be performed.
© 2020 by JSLS, Journal of the Society of Laparoscopic & Robotic Surgeons.

Entities:  

Keywords:  Cholecystitis; Laparoscopic Cholecystectomy; Postoperative Complications; Risk Factors; Scoring Methods

Mesh:

Year:  2020        PMID: 33144824      PMCID: PMC7592957          DOI: 10.4293/JSLS.2020.00049

Source DB:  PubMed          Journal:  JSLS        ISSN: 1086-8089            Impact factor:   2.172


INTRODUCTION

Laparoscopic cholecystectomy (LC) is an important approach for treating acute cholecystitis. The Tokyo Guidelines 2018 (TG18) proposed that after the cholecystitis severity has been assessed as mild or moderate, LC should be performed soon after the onset if the general condition of the patient suggests they are able to withstand surgery.[1-3] In cases of severe acute cholecystitis, the patient’s overall status is significantly deteriorated, and treatment should be selected based on a full and careful consideration of the patient’s background characteristics, including complications and comorbidities.[2] Every effort should be made to avoid risks in order to ensure LC is performed safely. The feasibility and safety of LC for acute cholecystitis in early management have been discussed in several studies, including the short postoperative stay and low morbidity and mortality as medical and economic benefits.[4-6] However, there are often cases with postoperative infectious and noninfectious complications after LC for acute cholecystitis, resulting in adverse economic and medical consequences.[6-9] It may therefore be useful to assess the risk of early postoperative complications of LC for acute cholecystitis using pre- and intra-operative data. The predictors of postoperative complications after LC discussed in past studies have included the age, gender, body mass index (BMI), total bilirubin, white blood cell (WBC) count, C-reactive protein (CRP) level, renal function, and ultrasound findings.[4,6-10] In the TG18, early LC is recommended if a patient’s general status is evaluated as good according to the criteria of the Charlson comorbidity index (CCI) and American Society of Anesthesiologists (ASA).[11] The objective of applying these criteria and the severity grade of acute cholecystitis is the safe management of LC. Therefore, these scoring systems may be useful for evaluating the risk of early postoperative complications after LC. However, few studies have evaluated the potential risk factors of early postoperative complications after LC using pre-, intra-, and postoperative factors of the general condition or data, and few scoring systems of risk factors for operative complications have been developed. The present study; therefore, aimed to identify potential risk factors for postoperative complications in LC according to the perioperative condition and scoring systems for postoperative complications.

MATERIALS AND METHODS

A total of 1026 patients underwent LC for cholecystolithasis or acute cholecystitis from January 2005 to December 2018. We defined “acute cholecystitis” based on the diagnostic criteria for acute cholecystitis in the TG18: (A) local signs of inflammation, including (1) Murphy’s sign and (2) right upper abdominal quadrant mass/pain/tenderness; (B) systemic signs of inflammation, including (1) a fever, (2) elevated CRP level, and (3) elevated WBC count; (C) imaging findings characteristic of acute cholecystitis, with a definite diagnosis of acute cholecystitis set as one item in A + one item in B + C. In the present study, “acute cholecystitis” was defined based on the definite diagnosis criteria, which included an elevated CRP level of ≥ 0.2 mg/dl and elevated WBC count of ≥ 9,000. We performed pre-operative biliary tract evaluations for all patients of cholecystitis with magnetic resonance cholangiopancreatography or drip infusion cholangiographic computed tomography. Four hundred twenty-three patients were registered in this study. One hundred thirty-nine patients who underwent cholecystectomy with a stone of the common bile duct were excluded. Of the remaining 887 patients, 437 without cholecystitis were excluded. The patients treated with initial open cholecystectomy were also excluded, but those who underwent conversion from laparoscopic to open cholecystectomy were included in this study. Laparoscopic cholecystectomy was performed by the four-port technique. Achievement of clinical view of safety (CVS) was set as a general rule in LC, and if we could not achieve CVS, LC was converted to open cholecystectomy. The background factors in LC (sex, age, comorbidity, grade of cholecystitis, pre-operative drainage of gallbladder, timing of LC, waiting time from onset to LC, and morbidity and mortality) were obtained from our database. We assessed the severity of postoperative complications according to the Clavien-Dindo classification. In our study, the patients were divided into two groups: those with Grade I or no complications (Group A) and those with Grade II or more severe postoperative complications (Group B) with regard to independent risk factors for morbidity. Surgical factors (severity of cholecystitis, external gallbladder drainage, cholecystectomy within 72 h from the onset, blood loss, operating time) and methods for evaluating the risk of perioperative complications were compared between the two groups with a univariate analysis. Independent risk factors of postoperative complications were then evaluated in a multivariate analysis using the factors extracted from the univariate analysis. In the analysis of the independent risk factors of postoperative morbidity and mortality, several scoring systems for predicting the postoperative morbidity and mortality were used. The ASA and Eastern Cooperative Oncology Group Performance Status were measures of the patients’ functional status and general health.[12,13] The CCI is used to categorize a patient’s comorbidities based on the International Classification of Diseases codes[2,14] (). The Physiological and Operative severity Score for enUmeration of Mortality and morbidity (POSSUM) is a simple scoring system previously validated for patients undergoing surgical treatment that estimates the risk of postoperative complications and death.[15] The POSSUM score involves a physiological score (PS), which contains 12 pre-operative physiological variables, and an operative severity score (OS), which contains six operative variables (). The Surgical Apgar Score (SAS) provides surgeons with a simple, objective, and direct rating of the operative performance and risk (). Charlson Comorbidity Index Physiological and Operative Severity Score for enUmeration of Mortality Scoring System POSSUM, Physiological and Operative severity Score for enUmeration of Mortality; R, morbidity; PS, physiological score; OS, operative severity score; COPD, chronic obstructive pulmonary disorder. Surgical Apgar Score Continuous parameters were expressed as the median and interquartile range. All statistical analyses were performed with R 3.5.2 (The R Foundation for Statistical Computing). The threshold of continuous data was detected with a receiver operating characteristic (ROC) curve. Fisher’s exact test was used for the analysis of categorical data. A logistic regression analysis was used for the multivariate analysis to identify the independent postoperative risk factors. This study was conducted with the approval of the JCHO Sendai South Hospital Ethics Committee. (2019-11-1)

RESULTS

A total of 423 cholecystitis patients were treated with laparoscopic cholecystectomy during the 14-year study period. The patients were 232 males (54.8%) and 191 females (45.2%), 19–95 years old (median, 65 years old), and 263 (62.2%) were ≥ 60 years of age. A total of 268 patients (63.4%) had comorbidities, including hypertension, cardiovascular disease, diabetes mellitus, and neurogenic and mental disorders, but the remaining 155 patients (36.6%) had no comorbidities. According to the severity grading of the TG18, the severity of 354 patients (83.7%) was Grade I (mild), that of 60 (14.2%) was Grade II (moderate), and that of 9 (2.1%) was Grade III (severe). External gallbladder drainage before cholecystectomy was performed for 19 patients (4.5%). Urgent laparoscopic cholecystectomy within 72 h from the onset was performed for 74 patients (17.5%). Conversion from laparoscopic to open cholecystectomy was needed in 33 patients (7.8%) (). The causes of moderate and severe cholecystitis are shown in .
Table 5.

Factors of Severity Grading for Acute Cholecystitis in TG 18

Group A
Group B
n%n%
Moderate cholecystitis48100.012100.0
 WBC count > 18,000/mm22041.6325.0
 Marked local inflammation1633.3650.0
 Duration of complaints > 72h918.8216.7
 Palpable tender mass36.318.3
Severe cholecystitis6100.03100.0
 Platelet count < 100,000/mm26100.0133.3
 Cardiovascular dysfunction00.0133.3
 Renal dysfunction00.0133.3

WBC; white blood cell.

Patient Characteristics, Severity Grading of Cholecystitis, Intraoperative Findings, and Postoperative Complications of Laparoscopic Cholecystectomy for Acute Cholecystitis Factors of Severity Grading for Acute Cholecystitis in TG 18 WBC; white blood cell. Eighteen patients (4.3%) experienced Grade ≥ 2 postoperative complications. Of these, surgical infectious complications included postoperative bile leak in one case, and subhepatic abscess in one case. Pulmonary complications were noted in five cases and cardiac complications in three cases. Postoperative cholangitis occurred in three cases (). There were two cases of in-hospital deaths: one due to acute postoperative heart failure the other due to exacerbation of liver failure caused by alcoholic liver cirrhosis (). This analysis indicated that the cause of Grade III (severe) cholecystitis in Group A was only a low platelet count, whereas the causes in Group B included cardiovascular dysfunction and renal dysfunction. Breakdown of Postoperative Complications in Laparoscopic Cholecystectomy for Acute Cholecystitis Details of Two Mortality Cases POSSUM, Physiological and Operative severity Score for enUmeration of Mortality. In accordance with our analysis of postoperative complications, a univariate analysis showed statistically significant differences between Groups A and B in pre-operative factors (Grade II [moderate] or Grade III [severe] cholecystitis), surgical factors (conversion to open cholecystectomy, cholecystectomy within 72 h from the onset), and all methodologies for evaluating postoperative risk factors (). We then performed a logistic regression analysis on the factors that were significantly different in the univariate analysis. The multivariate analysis revealed that the occurrence of Grade II (moderate) or Grade III (severe) cholecystitis and a POSSUM morbidity of ≥ 48.3 were independent risk factors of postoperative complications. The odds ratio of Grade II (moderate) or Grade III (severe) cholecystitis was 6.32, while that of POSSUM morbidity was 22.60 (). Prevalence of Postoperative Complications and Potential Risk Factors for Postoperative Complications in Laparoscopic Cholecystectomy for Acute Cholecystitis (Univariate and Multivariate Analysis) ECOG-PS, Eastern Cooperative Oncology Group Performance Status; ASA, American Society of Anesthesiologists; POSSUM, Physiological and Operative severity Score for enUmeration of Mortality; PS, physiological score; OS, operative severity score; SAS, Surgical Apgar Score.

DISCUSSION

We investigated the potential risk factors of early postoperative complications in LC. In the study period, 18 patients (4.3%) suffered from early postoperative complications of Grade II or worse. Surgical complications due to the surgical technique only occurred in two cases (bile leak and subhepatic abscess). Postoperative complications in nine cases were attributed to deterioration of the general condition (due to cardiac, pulmonary, or neurogenic diseases). The postoperative morbidity rate of 4.3% was less than or equal to the value in other studies, and the mortality was very low.[5,10],[16-19] Postoperative complications due to the surgical technique only occurred in two cases, so issues with our LC technique do not appear to be frequent. Instead, the exacerbation of the postoperative condition was the main concern in this study of complications. Two cases had Grade V complication in our hospital. Early LC was performed within 96 h for both cases, and the general condition was not improved in either case before LC. These LC procedures were performed prior to 2013, when TG13 was published. After 2013, we initially performed general organ support and conservative therapies with infusion, antibiotics, and percutaneous transhepatic gallbladder drainage (PTGBD). Elective cholecystectomy was performed after the improvement of the general condition, according to the flowchart in TG13 and TG18. We have therefore not experienced any cases of postoperative death following cholecystectomy since 2013. According to the TG18 severity grading for acute cholecystitis, the severity of 354 patients (83.7%) was Grade I (mild), that of 60 (14.2%) was Grade II (moderate), and that of 9 (2.1%) was Grade III (severe) in our database. However, Yokoe et al. reported in their Japan-Taiwan collaborative epidemiological study of AC that 2,130 patients (39.0%) were classified as Grade I (mild), 2,308 as Grade II (moderate), and 939 as Grade III (severe).[20] In our hospital, the rate of Grade I cholecystitis was higher than in that previous report. While the reason for this discrepancy is unclear, it may have been because our hospital was not a high-volume center for LC and did not have an emergency medical care center, so the proportion of patients with severe or moderate cholecystitis might have been relatively small. In Japan, LC is regularly performed for cholecystitis, not only at acute care centers, but also at small or midsize hospitals. The surgical technique and the methodology of perioperative care in LC are largely fixed by TG18 and the other studies. We do not believe there is any marked difference in the technique or quality of care between acute care centers and any other hospitals. In the present study, moderate (Grade I) or severe (Grade II) cholecystitis and POSSUM morbidity were found to be independent risk factors of postoperative complications. POSSUM is a method of estimating the risk of operative complications, including factors concerning the pre- and postoperative condition and data.[15] The results suggest that the high risk of postoperative complications for LC may be related to the perioperative general condition. TG18 recommends the general condition be evaluated with the CCI and ASA, in the flowchart of initial medical treatment and organ support, but studies concerning risk factors for postoperative complications in LC have thus far been insufficient.[11,21] Gigar et al. reported that an ASA score > 2, conversion to open surgery, emergency surgery, acute cholecystitis, old age, and intervention time were the predictive factors with the highest risk of inducing postoperative systemic complications in their analysis of 22,953 cases from a Swiss database.[22] Murphy et al. concluded that the complication rate of LC was 6.8%, and an advanced age, male gender, high CCI, comorbidities, and emergent LC were associated with postoperative complications in their nationwide inpatient sample.[23,24] Several studies also mentioned that the age, gender, comorbidity, BMI, presence of a fever, and conversion to open cholecystectomy were independent risk factors for postoperative complications in LC.[8,9,25,26] As described in these studies and TG18, the assessment of the patient’s general condition, which enables the prediction of the potential for postoperative complications, was very important for the perioperative management in LC. In the present study, LC for Grade II (moderate) or Grade III (severe) cholecystitis was also a potential risk factor for postoperative complications. The TG18 and several studies showed that the rate of postoperative complications and conversion to open cholecystectomy in LC for moderate or severe cholecystitis was higher than in LC for mild cholecystitis.[1,25,27] Severe cholecystitis was diagnosed in three patients with complications after LC. The causal parameters for two of those cases were cardiac and renal dysfunction, while the third case had thrombocytopenia (platelet count under 100,000). While patients with severe cholecystitis due to a low platelet count can undergo LC without postoperative complications, cases of severe cholecystitis with organ dysfunction, such as cardiac and renal dysfunction, were noted only in the group with postoperative complications. Both patients with organ dysfunction died after LC. LC for acute cholecystitis with organ dysfunction can be a deadly procedure, so the general condition of the patient needs to be improved before LC is performed. As such, the ideal approach for risk management in cases of LC for severe cholecystitis patients with organ failure should be differentiated from that in patients being treated for severe cholecystitis with a low platelet count. Given the present findings of POSSUM morbidity and severity of cholecystitis as potential risk factors, these factors may be used to predict and prevent postoperative complications. The prevention of postoperative complications using these factors is particularly important. There are several methods of improving the preoperative condition in cases of cholecystitis. The TG18 recommended antimicrobial therapy and PTGBD be performed for acute cholecystitis patients with a high surgical risk as an alternative to urgent LC.[28] Indeed, the pre-operative use of antibiotics for conservative therapy followed by cholecystectomy is reported to be quite effective.[29] PTGBD is a method of improving acute cholecystitis, and its therapeutic role in patients with severe or moderate cholecystitis has been discussed in several studies.[27,29] The present findings showed that PTGBD was performed for only 4.5% of patients with cholecystitis, and urgent LC in 72 h was performed for only 17.5% of cases. TG18 recommended early LC for Grade I (mild) cholecystitis, and antibiotics and general supportive care initially for Grade II (moderate) cholecystitis, followed by early or elective LC.11 Our study showed that the rate of LC within 72 h from the onset of cholecystitis in Group B was higher than that in Group A. This result, which contrasts with that from the TG18 recommendation of early LC, suggests that conservative treatments for cholecystitis followed by elective LC might not increase complications after LC. LC was not performed for the remaining 78% within 72 h from the onset because many patients did not visit our hospital within 72 h from the onset due to the mild nature of their symptoms, or they had already received conservative treatments at other institutes before their arrival. In addition, our hospital did not have a system for performing emergency operations, so conservative treatments were required before LC could be performed. Our hospital treats many older patients with cholecystitis and accompanying comorbidities. Early LC for older patients without an assessment of the general condition can be dangerous due to the risk of deterioration of the comorbidities and general condition after LC. For these patients, elective LC followed by an adequate assessment of comorbidities is suitable. While preoperative antibiotics and PTGBD may be useful for preventing postoperative complication, other methods of improving the preoperative condition have rarely been discussed. The POSSUM morbidity score involves the PS, which contains 12 pre-operative physiological variables, and the OS, which contains six operative variables.[15] The PS and OS may be targets for improving the conditions in patients undergoing LC. In the PS of POSSUM, the parameters of hemoglobin, WBC count, urea, sodium, and potassium can be easily improved before LC with appropriate fluid replacement and antibiotics. However, no effective methods for improving the factors associated with the OS have yet been established for LC. Reducing blood loss during LC may be the only viable method, but its effect may be negligible because of the generally small amount of bleeding in LC. The POSSUM morbidity includes both the pre- and intraoperative condition. Therefore, the pre-operative prediction of postoperative complications in LC might not be feasible. The POSSUM PS reflects the pre-operative condition of patients, so the PS score may vary widely among patients. The POSSUM OS is an intra-operative score that depends on the operative procedure, such as cholecystectomy for cholecystitis. The OS score can be predicted based in part on the severity of cholecystitis. If the POSSUM morbidity exceeds the cut-off point after LC, then the postoperative management of the patient’s general condition may be challenging. Intensive medical care should therefore be carried out for patients with a high POSSUM score. Preoperative conservative treatments before LC is very important if the PS is high. Therefore, assessing the POSSUM morbidity before LC is important. The POSSUM is used to analyze the risk of postoperative complications in many operative procedures. However, such analyses for LC have been rare. Tambyraja et al. showed that the POSSUM score performed well for predicting morbidity after LC in patients ≥ 80 years old.[30] In the present study, a total of 33 cases of LC were converted to open cholecystectomy during surgery in our hospital. The reason for conversion to open cholecystectomy in almost all cases was difficulty performing LC due to advanced inflammation, fibrosis, and adhesion of the gallbladder. Difficulty performing LC may lead to postoperative complications. Several studies have found that conversion to open cholecystectomy in LC was a risk factor for postoperative complications.[7,8,22] In the present study, however, conversion to open cholecystectomy was not a risk factor of postoperative complications after LC, although why this was true was unclear. In addition, no study has yet described the usefulness of conversion to open cholecystectomy. We suspect that conversion to open cholecystectomy is not necessarily a risk factor for postoperative complications after LC, as morbidity due to the surgical technique was shown to be rare in our hospital. An appropriate conversion strategy may help prevent postoperative complications. Future reports on the appropriate timing and indications for conversion to open cholecystectomy are awaited. Our study on the potential risk factors of postoperative complications associated with LC is expected to improve the management of the perioperative condition of such patients. However, this study has several limitations that should be considered when interpreting the results. First, this study was a retrospective study using information obtained from the database of operations in our hospital. Second, there were likely several sources of selection bias due to the exclusion of cases in which open cholecystectomy was performed from the start. These cases may have had more severe cholecystitis than those involving LC (with or without conversion). Another limitation was probably the heterogeneity of the operators, but all of the operators had seven or more years of surgical experience in our institution, so the heterogeneity was likely small.

CONCLUSION

According to the present study, POSSUM morbidity and moderate or severe cholecystitis were potential risk factors of postoperative complications. The preoperative management of the general condition and cholecystitis using antibiotics, infusion, and PTGBD may therefore help prevent postoperative complications. Once the POSSUM morbidity reaches the threshold after LC, postoperative management becomes difficult, so strict control of the general condition should be performed.
Table 1.

Charlson Comorbidity Index

Assigned Weights for Diseases
1Myocardial infarction
Congestive heart failure
Peripheral vascular disease
Cerebrovascular disease
Dementia
Chronic pulmonary disease
Connective tissue disease
Peptic ulcer disease
Mild liver disease
Diabetes mellitus
2Hemiplegia
Moderate or severe chronic kidney disease
Diabetes mellitus with end-organ damage
Any solid tumor
Leukemia
Malignant lymphoma
3Moderate or severe liver disease
6Metastatic solid tumor
Acquired immune deficiency syndrome
Table 2.

Physiological and Operative Severity Score for enUmeration of Mortality Scoring System

The Equations for POSSUM: ln [R / (1–R)] = −5.91 + (0.16 × PS) + (0.19 × OS)
PS
1248
Age (years)≦ 6061–70≧ 71
Cardiac signs, chest radiographNo failureDiuretic, digoxin, antianginal, or hypertensive therapyPeripheral edema, warfarin therapy, borderline cardiomegalyRaised jugular venouspressure, cardiomegaly
Respiratory historyNo dyspneaDyspnoea on exertion, Mild COPDLimiting dyspnoea, Moderate COPDDyspnea on rest, Fibrosis or consolidation
Systolic blood pressure (mmHg)110–130100–109, 131–17090–99, ≧ 171≦ 89
Pulse rate (Beats/min)50–8040–49, 81–100101–120≦ 39, ≧ 121
Glasgow coma score1512–149–11≦ 8
Hemoglobin (g/100 ml)13–1611.5–12.9, 16.1–17.010.0–11.4, 17.1–18.0≦ 9.9, ≧ 18.1
White cell count (nmol/mm3)4,000–10,0003,100–4,00010,100–20,000≦ 3,000, ≧ 20,100
Plasma urea (nmol/L)≦ 7.57.6–10.010.1–15.0≧ 15.1
Plasma sodium (nmol/L)≧ 136131–135126–130≦ 125
Plasma potassium (nmol/L)3.5–5.03.2–3.4, 5.1–5.32.9–3.1, 5.4–5.9≦ 2.8, ≧ 6.0
ElectrocardiogramNormalAtrial fibrillation (rate 60–90)Any other abnormalrhythm or Q waves or ST/T wave changes
OS
1248
Operation gradeMinorModerateMajorMajor +
Multiple procedures12>2
Blood loss (ml)≦ 100101–500501–999≧ 1000
Peritoneal soilingNoneMinor (serous fluid)Local pusFree bowel content, pus, or blood
MalignancyNonePrimary onlyNodal metastasesDistant metastases
Mode of surgeryElectiveEmergency resuscitation of > 2h possible, Operation < 24h after admissionEmergency (immediate surgery < 2h needed)

POSSUM, Physiological and Operative severity Score for enUmeration of Mortality; R, morbidity; PS, physiological score; OS, operative severity score; COPD, chronic obstructive pulmonary disorder.

Table 3.

Surgical Apgar Score

Points01234
Estimated blood loss (ml)> 1000601–1000101–600< 100
Lowest mean arterial pressure (mmHg)> 4040–5455–69≧ 70
Lowest heart rate (/min)> 8576–8566–7556–6555 ≧
Table 4.

Patient Characteristics, Severity Grading of Cholecystitis, Intraoperative Findings, and Postoperative Complications of Laparoscopic Cholecystectomy for Acute Cholecystitis

n%
Gender
 Male23254.8
 Female19145.2
Age
 < 404610.9
 40–494310.2
 50–597116.8
 60–699923.4
 70–799923.4
 80–896014.2
 > 9051.2
Comorbidity
 Hypertension17942.3
 Cardiovascular4410.4
 Respiratory225.2
 Neurogenic and mental disorder4510.6
 Diabetes mellitus7317.3
 Other7718.2
 None15536.6
Severity grade of cholecystitis
 Grade I (mild)35483.7
 Grade II (moderate)6014.2
 Grade III (severe)92.1
External gallbladder drainage
 Yes194.5
 No40495.5
Urgent cholecystectomy
 Yes7417.5
 No34882.5
Conversion to open cholecystectomy
 Yes337.8
 No39092.2
Clavien-Dindo classification
 No complication38891.8
 Grade I174.0
 Grade II92.1
 Grade III a40.9
 Grade III b00.0
 Grade IV a30.7
 Grade IV b00.0
 Grade V20.5
 ≥ Grade II184.3
Table 6.

Breakdown of Postoperative Complications in Laparoscopic Cholecystectomy for Acute Cholecystitis

n
Surgical infectious2
 Bile leakage1
 Subhepatic abscess1
Nonsurgical infectious16
 Paralytic ileus3
 Pulmonary5
 Cardiac3
 Cholangitis3
 Neurologic1
 Liver failure1
Table 7.

Details of Two Mortality Cases

Case 1Case 2
Age8881
GenderMaleMale
ComorbidityHypertension, Chronic kidney disease, Diabetes mellitus, Chronic heart failureHypertension, Diabetes mellitus,
Alcoholic liver cirrhosis
Cholecystitis gradingGrade IIIGrade III
Gallbladder drainageNoNo
Early cholecystectomy in 72 hYesNo
Postoperative courseAcute heart failure, Ventricular fibrillationLiver failure
American Society of Anesthesiologists44
Charlson comorbidity index44
Eastern Cooperative Oncology Group Performance Status33
POSSUM morbidity88.898.9
Surgical Apgar Score65

POSSUM, Physiological and Operative severity Score for enUmeration of Mortality.

Table 8.

Prevalence of Postoperative Complications and Potential Risk Factors for Postoperative Complications in Laparoscopic Cholecystectomy for Acute Cholecystitis (Univariate and Multivariate Analysis)

Univariate Analysis
Multivariate Analysis
Group AGroup BP ValueOdds ratio95% CIP Value
Moderate or severe cholecystitis
 Yes5415< 0.0016.321.00 – 39.900.049
 No3513
External gallbladder drainage
 Yes1620.175
 No38916
Operation within 72 h from onset
 Yes6680.0061.310.28 – 6.160.730
 No33910
Conversion to open cholecystectomy
 Yes267< 0.0010.950.11 – 8.050.963
 No37911
Blood loss
  ≥ 112 ml4410< 0.0012.450.22 – 26.80.463
 < 112 ml3618
Operating time
  ≥ 117 min15515< 0.0015.280.88 – 31.800.070
 < 117 min2503
ECOG-PS
  ≥ 3430.0020.060.00 – 8.150.261
 < 340115
ASA
  ≥ 304< 0.0011.10 × 10100.00 – ∞0.999
 < 340514
CCI
  ≥ 3105< 0.0015.100.09 – 288.000.429
 < 339513
POSSUM PS
  ≥ 26.011713< 0.0010.290.02 – 3.650.338
 < 26.02885
POSSUM OS
 ≥ 87715< 0.0011.040.12 – 8.960.969
 < 83293
POSSUM morbidity
  ≥ 48.33614< 0.00122.601.46 – 350.000.026
 < 48.33694
SAS
  ≤ 818818< 0.0015.06 × 1070.00 – ∞0.992
 > 82170

ECOG-PS, Eastern Cooperative Oncology Group Performance Status; ASA, American Society of Anesthesiologists; POSSUM, Physiological and Operative severity Score for enUmeration of Mortality; PS, physiological score; OS, operative severity score; SAS, Surgical Apgar Score.

  30 in total

1.  Laparoscopic cholecystectomy for acute cholecystitis: how do fever and leucocytosis relate to conversion and complications?

Authors:  S Halachmi; N DiCastro; I Matter; A Cohen; E Sabo; J G Mogilner; J Abrahamson; S Eldar
Journal:  Eur J Surg       Date:  2000-02

2.  POSSUM: a scoring system for surgical audit.

Authors:  G P Copeland; D Jones; M Walters
Journal:  Br J Surg       Date:  1991-03       Impact factor: 6.939

3.  POSSUM scoring for laparoscopic cholecystectomy in the elderly.

Authors:  Andrew L Tambyraja; Sudhir Kumar; Stephen J Nixon
Journal:  ANZ J Surg       Date:  2005-07       Impact factor: 1.872

Review 4.  Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).

Authors:  Masamichi Yokoe; Jiro Hata; Tadahiro Takada; Steven M Strasberg; Horacio J Asbun; Go Wakabayashi; Kazuto Kozaka; Itaru Endo; Daniel J Deziel; Fumihiko Miura; Kohji Okamoto; Tsann-Long Hwang; Wayne Shih-Wei Huang; Chen-Guo Ker; Miin-Fu Chen; Ho-Seong Han; Yoo-Seok Yoon; In-Seok Choi; Dong-Sup Yoon; Yoshinori Noguchi; Satoru Shikata; Tomohiko Ukai; Ryota Higuchi; Toshifumi Gabata; Yasuhisa Mori; Yukio Iwashita; Taizo Hibi; Palepu Jagannath; Eduard Jonas; Kui-Hin Liau; Christos Dervenis; Dirk J Gouma; Daniel Cherqui; Giulio Belli; O James Garden; Mariano Eduardo Giménez; Eduardo de Santibañes; Kenji Suzuki; Akiko Umezawa; Avinash Nivritti Supe; Henry A Pitt; Harjit Singh; Angus C W Chan; Wan Yee Lau; Anthony Yuen Bun Teoh; Goro Honda; Atsushi Sugioka; Koji Asai; Harumi Gomi; Takao Itoi; Seiki Kiriyama; Masahiro Yoshida; Toshihiko Mayumi; Naoki Matsumura; Hiromi Tokumura; Seigo Kitano; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2018-01-09       Impact factor: 7.027

Review 5.  Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.

Authors:  Harumi Gomi; Joseph S Solomkin; David Schlossberg; Kohji Okamoto; Tadahiro Takada; Steven M Strasberg; Tomohiko Ukai; Itaru Endo; Yukio Iwashita; Taizo Hibi; Henry A Pitt; Naohisa Matsunaga; Yoriyuki Takamori; Akiko Umezawa; Koji Asai; Kenji Suzuki; Ho-Seong Han; Tsann-Long Hwang; Yasuhisa Mori; Yoo-Seok Yoon; Wayne Shih-Wei Huang; Giulio Belli; Christos Dervenis; Masamichi Yokoe; Seiki Kiriyama; Takao Itoi; Palepu Jagannath; O James Garden; Fumihiko Miura; Eduardo de Santibañes; Satoru Shikata; Yoshinori Noguchi; Keita Wada; Goro Honda; Avinash Nivritti Supe; Masahiro Yoshida; Toshihiko Mayumi; Dirk J Gouma; Daniel J Deziel; Kui-Hin Liau; Miin-Fu Chen; Keng-Hao Liu; Cheng-Hsi Su; Angus C W Chan; Dong-Sup Yoon; In-Seok Choi; Eduard Jonas; Xiao-Ping Chen; Sheung Tat Fan; Chen-Guo Ker; Mariano Eduardo Giménez; Seigo Kitano; Masafumi Inomata; Shuntaro Mukai; Ryota Higuchi; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2018-01-09       Impact factor: 7.027

Review 6.  Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis.

Authors:  Toshihiko Mayumi; Kohji Okamoto; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; David Schlossberg; Henry A Pitt; Masahiro Yoshida; Harumi Gomi; Fumihiko Miura; O James Garden; Seiki Kiriyama; Masamichi Yokoe; Itaru Endo; Horacio J Asbun; Yukio Iwashita; Taizo Hibi; Akiko Umezawa; Kenji Suzuki; Takao Itoi; Jiro Hata; Ho-Seong Han; Tsann-Long Hwang; Christos Dervenis; Koji Asai; Yasuhisa Mori; Wayne Shih-Wei Huang; Giulio Belli; Shuntaro Mukai; Palepu Jagannath; Daniel Cherqui; Kazuto Kozaka; Todd H Baron; Eduardo de Santibañes; Ryota Higuchi; Keita Wada; Dirk J Gouma; Daniel J Deziel; Kui-Hin Liau; Go Wakabayashi; Robert Padbury; Eduard Jonas; Avinash Nivritti Supe; Harjit Singh; Toshifumi Gabata; Angus C W Chan; Wan Yee Lau; Sheung Tat Fan; Miin-Fu Chen; Chen-Guo Ker; Yoo-Seok Yoon; In-Seok Choi; Myung-Hwan Kim; Dong-Sup Yoon; Seigo Kitano; Masafumi Inomata; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-12-16       Impact factor: 7.027

7.  A 10-year experience with the use of laparoscopic cholecystectomy for acute cholecystitis: is it safe?

Authors:  M Suter; A Meyer
Journal:  Surg Endosc       Date:  2001-08-16       Impact factor: 4.584

8.  Predictors of major complications after laparoscopic cholecystectomy: surgeon, hospital, or patient?

Authors:  Melissa M Murphy; Sing-Chau Ng; Jessica P Simons; Nicholas G Csikesz; Shimul A Shah; Jennifer F Tseng
Journal:  J Am Coll Surg       Date:  2010-05-26       Impact factor: 6.113

Review 9.  Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.

Authors:  Kohji Okamoto; Kenji Suzuki; Tadahiro Takada; Steven M Strasberg; Horacio J Asbun; Itaru Endo; Yukio Iwashita; Taizo Hibi; Henry A Pitt; Akiko Umezawa; Koji Asai; Ho-Seong Han; Tsann-Long Hwang; Yasuhisa Mori; Yoo-Seok Yoon; Wayne Shih-Wei Huang; Giulio Belli; Christos Dervenis; Masamichi Yokoe; Seiki Kiriyama; Takao Itoi; Palepu Jagannath; O James Garden; Fumihiko Miura; Masafumi Nakamura; Akihiko Horiguchi; Go Wakabayashi; Daniel Cherqui; Eduardo de Santibañes; Satoru Shikata; Yoshinori Noguchi; Tomohiko Ukai; Ryota Higuchi; Keita Wada; Goro Honda; Avinash Nivritti Supe; Masahiro Yoshida; Toshihiko Mayumi; Dirk J Gouma; Daniel J Deziel; Kui-Hin Liau; Miin-Fu Chen; Kazunori Shibao; Keng-Hao Liu; Cheng-Hsi Su; Angus C W Chan; Dong-Sup Yoon; In-Seok Choi; Eduard Jonas; Xiao-Ping Chen; Sheung Tat Fan; Chen-Guo Ker; Mariano Eduardo Giménez; Seigo Kitano; Masafumi Inomata; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-12-20       Impact factor: 7.027

10.  Complications of Laparoscopic Cholecystectomy: Our Experience from a Retrospective Analysis.

Authors:  Miodrag Radunovic; Ranko Lazovic; Natasa Popovic; Milorad Magdelinic; Milutin Bulajic; Lenka Radunovic; Marko Vukovic; Miroslav Radunovic
Journal:  Open Access Maced J Med Sci       Date:  2016-11-09
View more
  1 in total

1.  Elective laparoscopic cholecystectomy: recurrent biliary admissions predispose to difficult cholecystectomy.

Authors:  James Lucocq; John Scollay; Pradeep Patil
Journal:  Surg Endosc       Date:  2022-01-13       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.